Upload
others
View
5
Download
0
Embed Size (px)
Citation preview
Curriculum Vitae Dr. Ali Eslamifar
1
BIOGRAPHICAL
Name: Ali Eslamifar, M.D., ACP
“Professor of Pathology.Head of the Clinical Research Dept. of the Pasteur Institute of Iran”
Address: Electron Microscopy and Clinical Research Department, Pasteur Institute of Iran (IPI), No. 69,
Pasteur Ave., Tehran 1316943551, Iran
Birth Date: September , 06, 1962
Tel/fax: +98-21 64112805
Mobile: +98-912 1095759
E-mail: [email protected] , [email protected]
EDUCATION Years attended 1989-1996
Degree or received MD
Institution Shaheed Beheshti University of Medical Sciences and Health Services
Years attended 1997-2001
Degree or received Anatomical & Clinical Pathology (ACP)
Institution Shaheed Beheshti University of Medical Sciences and Health Services
Years attended 2001
Degree or received Electron microscopy
Institution Shaheed Beheshti University of Medical Sciences and Health Services
Curriculum Vitae Dr. Ali Eslamifar
2
Executive Records Organization Positions Row
Pasteur Institute of Iran Director and Head of Clinical Research Dept. 1
Pasteur Institute of Iran Director of clinical research, epidemiology and
biostatistics at the Pasteur Institute of Iran 2
Pasteur Institute of Iran Head of vaccination Dept 3
Pasteur Institute of Iran Director and Head of Electron Microscopy Dept 4
Pasteur Institute of Iran Medical Ethics Committee 5
Pasteur Institute of Iran Deputy Director for Specialized Sceintific Services 6
Curriculum Vitae Dr. Ali Eslamifar
3
Publications ISI (International):
Cod
Title Authors Journal Information
Journal Name IF Date No
1
Assesment of the association between human
Papillomavirus infection and breast carcinoma
Ali Eslamifar, Amitis Ramezani, Kayhan Azadmanesh, Farahnaz Bidari-
Zerehpoosh, Mohammad Banifazl, Arezoo Aghakhani
Iranian Journal of Patholpgy ISI
2015
(2015)
10 (
1)
2 Lack of human papillomavirus DNA in colon
adenocarcinama and adenoma
Arezoo Aghakhani, Rasool Hamkar, Amitis Ramezani, Farahnaz Bidari- Zerehpoosh,
Shahram Sabeti, Nastaran Ghavami Mohammad Banifazl, Niloofar Rashidi,
Ali Eslamifar
Journal of Cancer Research and Therapeutics
ISI
2015
Volu
me
10 -
Iss
ue
3
3
Neutralizing Antibody Response after Intramuscular
Purified Vero Cell Rabies Vaccination (PVRV) in Iranian
Patients with Specific Medical Conditions
Rahimi P, Vahabpour R, Aghasadeghi MR, Sadat SM, Howaizi N, Mostafavi E,
Eslamifar A, Fallahian V PLOS ONE ISI
2015
DO
I:10.1
371
Curriculum Vitae Dr. Ali Eslamifar
4
4
Occult hepatitis C virus infection in Iranian hemodialysis
patients
Ali Eslamifar · Amitis Ramezani · Hassan Ehteram · Effat Razeghi ·
Farrokhlagha Ahmadi · Manouchehr Amini · Mohammad Banifazl · Gelavizh
Etemadi · Hossein Keyvani · Anahita Bavand · Arezoo Aghakhani
Journal of Nephropathology ISI
2015
2015;4
(4):
116
-120
5 Frequency and Genotype of Human Parvovirus B19
Among Iranian Patients Infected With HIV
Kayhan Azadmanesh · Minoo Mohraz · Monireh Kazemimanesh · Aghakhani ·
Maryam Foroughi · Mohammad Banifazl, · Ali Eslamifar , Amitis Ramezani
Journal of Medical Virology ISI
2015
87:1
124
–1129
6
Lack of Association between Interleukin-10 Gene
Promoter Polymorphisms with HIV Susceptibility and
Progression to AIDS
Amitis Ramezani · Ebrahim Kalantar · Arezoo Aghakhani · Mohammad
Banifazl · Maryam Foroughi · Soudabeh Hosseini · Ali Eslamifar · Ali
Esmaeilzadeh · Porisa Sadrpoor · Minoo Mohraz
Iranian Journal of Pathology ISI
2015
10 (
2),
141 -
148
7
Bariatric Surgery for Morbid Obesity: Tehran
Obesity Treatment Study (TOTS) Rationale and
Study Des
M Barzin, F Hosseinpanah, MA Motamedi, P Shapoori, P Arian, MA
Daneshpour, G Asghari, A Teymoornejad, A Eslamifar, D Khalili, B Jodeiri, S Alamdari, F Azizi, A Khalaj
JMIR Res Protoc ISI
2015
5(1
): e
8
8 Immune Response to Standard Hepatitis B
Vaccination in HIV - Infected Patients
Amitis Ramezani , Minoo Mohraz, Mohammad Banifazl, Maryam Foroughi
Ali Eslamifar Arezoo Aghakhani Vaccine Research ISI
2015
Volu
me1
-N
um
ber
2
Curriculum Vitae Dr. Ali Eslamifar
5
9 Prevalence of BK virema in Iranian hemodialysis
and peritoneal dialysis pationts
Sharif A, Sharif MR, Aghakhani A, BanifazlM, Hamkar R, Ghavami N, Eslamifar A,
Ramezani A
Vaccine Research ISI 2015
Volu
me1
-N
um
ber
2
10 Identification of the main allergen sensitizers in an
Iran asthmatic population by molecular diagnosis
Fardis Teifoori Masoomeh Shams-Ghahfarokhi, Idoia Postigo, Mehdi Razzaghi-Abyaneh, Ali Eslamifar,
Antonio Gutiérrez, Ester Suñén and Jorge Martínez
Allergy, Asthma & Clinical Immunology ISI
2014
2014, 10:4
1
11 Hematological Reference Values for Healthy Males
in the Central Part of Iran
Amitis Ramezani1, Mandana Shams, Zarinfar, Mohammad Banifazl, Arezoo Aghakhani, Ali Eslamifar, Fatemeh- Alsadat Mahdaviani, Ghorban Deiri ,
Masoomeh Sofian
Iranian Journal of Pathology ISI
2014
9 (
1),
50
- 55
12
Efficacy of Cisplatin-loaded polybutyl
cyanoacrylate nanoparticles on the glioblastoma
Ebrahimi hahmabadi & ovahedi
& Maedeh Koohi Esfahani
Ali EslamifarEbrahim Alavi &
& Gholamreza Mohammadi
Anaraki & Azim Akbarzadeh
Tumor Biol ISI
2014
35:4
799
–4806
13
Serological response to one intradermal or
intramuscular hepatitis B virus vaccine booster
dose in human immunodeficiency virus-infected
nonresponders to standard vaccination
Ramezani, Alireza Janbakhsh1,
mohammadi, Mohammad
Banifazl, Arezoo Aghakhani,
rnasiri, , PouAli Eslamifar
Behzad Mahdavian, Asghar
Farazi, Masoomeh Sofian
Perspectives in Clinical Research ISI
2014
Vol
5 |
Issu
e 3
Curriculum Vitae Dr. Ali Eslamifar
6
14 Isolated Anti-HBc and Occult HBV Infection in
Dialysis Patients
Ramezani; Mohammad
Aghasadeghi; Ahmadi; Effat
*;Ali Eslamifar; Razeghi
Mohammad Banifazl;
Masoomeh Sofian; Golnaz
Bahramali; Soheila Hekmat;
Aghakhani,
Nephro Urol Mon ISI
2014
7(1
): e
22674
15 Immunity to diphtheria and tetanus among blood
donors in Arak, central province of Iran
Amitis ,Ali Eslamifar
Ramezani, Mohammad Banifaz,
Masoomeh Sofian, Fatemeh-
Alsadat Mahdaviani, Farhad
Yaghmaie, Arezoo Aghakhani
Pharmaceutical biolog ISI
2014
50, 1416
-1422
16 No evidence for occult HBV infection in hepatitis
B vaccine non-responders
Mohammad Reza Aghasadeghi,
Mohammad Banifazl, Arezoo
,Ali EslamifarAghakhani,
Rouhollah Vahabpour 1 and
Amitis Ramezani
IRAN. J. MICROBIOL ISI
2014
. V
ol.
6, N
o 5
350-3
53
17
: Immunogenicity Evaluation of a Rationally
Designed Polytope Construct Encoding HLA-
A*0201 Restricted Epitopes Derived from
Leishmania major Related Proteins in HLA-
A2/DR1 Transgenic Mice: Steps toward Polytope
Vaccines
Negar Seyed, Charline Vauchy,
Ali Magalie Dosset Yann Godet,
, Iraj Sharifi, Olivier Eslamifar
Adotevi, Christophe Borg Pierre
Simon Rohrlich, Sima Rafati1
Polytope Construct Including Leishmania
Peptides ISI
2014
Volu
me
9 |
Issu
e 10
| e108848
18
Comparison of two durations of triple-drug therapy
in patients with uncomplicated brucellosis: A
randomized controlled trial
Masoomeh Sofian · Ali-Akbar
Velayati · Arezoo Aghakhani ·
Willi McFarland · Ali-Asghar
Farazi · Mohammad Banifazl ·
· Amitis Ali Eslamifar
Ramezani
Scandinavian Journal of Infectious Diseases ISI
2014
46:
573
–577
Curriculum Vitae Dr. Ali Eslamifar
7
19
HCV, HBV, and HIV seroprevalence, coinfections,
and related behaviors among male injection
drug users in Arak, Iran
Ramezania, Reihaneh
Amirmoezib, Jonathan E. Volkc,
Aghakhania, Zarinfard,
McFarlande Banifazlf,
and Ali EslamifaraMostafavig,
Masoomeh Sofiand
dx.doi.org ISI 2014
10.1
080/0
9540121
.2014.8
82485
20
Hepatitis E virus infection in patients infected with
human immunodeficiency virus in an endemic area
in Iran
Amitis Ramezani, Velayati, -
, Ali EslamifarSarvestani,
Minoo Mohraz4, Mohammad
Banifazl5, Farahnaz Bidari-
Zerehpoosh6, Farhad
Yaghmaei1, Willi McFarland7,
Maryam Foroughi4, Hossein
Keyvani8, Ehsan Mostafavi and
Arezoo Aghakhani
International Journal of STD & AIDS ISI
2014
24(1
0)
21
The Effect of Candida Albicans Systemic Infection
on Matrix Metalloproteinases in Breast Cancer
Bearing Balb/c Mice
Fatemeh Hajari Taheri,
Seyedolmohadesin , Mansour
Bayat, Mahdavi, Mohammad
and Ali EslamifarYazdi,
Mohsenv bolhassani
Iran J Allergy Asthma Immunol ISI
2013
12(1
):81
-85
22
Frequency and Genotype of Hepatitis D Virus
Infection in Patients Infected with HIV and Those
Undergoing Hemodialysis
Aghasadeghi 1, Mohraz 2,
Golnaz Bahramali 1, Aghakhani
3, Banifazl 4, Maryam Foroughi
Ali 2, Farrokhlagha Ahmadi 5,
Mehdi Sadat 1, Eslamifar*,
Ramezani 3
Hepat Mon ISI
2013
13(5
):e7
481
23
No Correlation Between Interleukin-10 Gene
Promoter Polymorphisms and Hepatitis B Virus
Infection Outcome
Masoomeh Sofian, Ebrahim
Kalantar, Arezoo Aghakhani,
Soudabeh Hosseini, Mohammad
Ali EslamifarBanifazl,
jourabchi 5, Ali Asghar Farazi 1,
Amitis Ramezani 3
Hepat Mon. ISI
2013
13(5
):e8
803
Curriculum Vitae Dr. Ali Eslamifar
8
24 Low Prevalence of Brucella agglutinins in Blood
Donors in Central Province of Iran
Sofian1, Mehrnoosh
Sheikholeslami2, Fatemeh-
Mahdaviani3, Aghakhani4,
Ali Mohammad Banifazl5,
, Sarmadian1, Eslamifar
Ghorban Deiri3, Amitis
Ramezani
IRAN. J. MICROBIOL ISI
2013
Vol.
5, N
o. 1
(Mar
ch 2
013
), 2
4-
27
25
Seroprevalence of Hepatitis E Virus infection
among volunteer blood donors in central province
of Iran in 2012
Hassan Ehteram1, Amitis
, EslamifarAli Ramezani2,
Masoomeh Sofian3, Mohammad
Banifazl4, Shahin Ghassemi5,
Arezoo Aghakhani2, Parisa
Mashayekhi
IRAN. J. MICROBIOL. ISI
2013
Vol.
5,
No. 2
(June
2013),
172-1
76
26 Screening of family members of patients with acute
brucellosis in an endemic area of Iran
Masoomeh Sofian1, Leila
Safaeipour2, Arezoo
Aghakhani3, Mohammad Reza
Sharif4, Mohammad Banifazl5,
Alireza Sharif6, Ali-Asghar
,EslamifarAli Farazi1,
Farshideh Didgar1, Amitis
Ramezani
IRAN. J. MICROBIOL ISI
2013
Vol.
5, N
o. 3
(Sep
tem
ber
2013),
215-2
19
27
Importance of Isolated Anti‐HBc in Detection of
Occult Hepatitis B Virus Infection in Hemodialysis
Patients
M A Eslamifar,Ramezani,
Banifazl, A Aghakhani
Nephro Urol Mon ISI
2013
7(1
): e
22674.
28
Differentiation of Brucella -Induced Epididymo-orchitis
from Nonspe-cific Epididymo-orchitis in an Endemic Area
for Bru
cellosis
A Ramezani, Masoomeh Sofian , Arezoo
Aghakhani, Mohammad Banifazl, Ali
Eslamifar, Fatemeh Zolfaghari, Hossein
Sarmadian, Amitis Ramezani
Med Microbiol Infec Dis ISI
2013
1(1
): 8
-13
Curriculum Vitae Dr. Ali Eslamifar
9
29 Outcome of hemodialysis patients with occult
hepatitis B virus infection at a 4 year follow-up
Ramezani A, Banifazl M,
, Ahmadi F, Eslamifar A
.Aghakhani A, Razeghi E
J Gastrointestin Liver Dis. ISI
2013
2013
Mar
;22(1
):111
-2.
30
Immunomodulatory effects of IP-10 chemokine
along with PEI600-Tat delivery system in DNA
vaccination against HPV infections
Mohit E1, Bolhassani A,
Zahedifard F, Seyed N,
, Taghikhani M ,Eslamifar A
Samimi-Rad K, Rafati S
Mol Immunol. ISI
2013
07.0
11. E
pub 2
012
Aug 2
5..
31
Rabies antibody levels in pregnant women and
their newborns after rabies post-exposure
prophylaxis
Ahmad Fayaz¹ D.V.M., Susan
Ali Simani¹ Vida Fallahian
³ M.D., Mahboob ²,Eslamifar
Hazrati² M.D., Firoozeh
Farahtaj¹ M.L.D, Nader
Howaizi¹ B.Sc., Peivand Biglari¹
B.Sc
Iran J Reprod Med
ISI
2013
Vol.
10. N
o.2
.
32 Tetanus and Diphtheria Seroprevalence in Patients
Infected With Human Immunodeficiency Virus
, Amitis Ali Eslamifar1
Ramezani1, Mohammad
Banifazl2, Arezoo Aghakhani
IRANIAN JOURNAL OF PATHOLOGY ISI
2013
Vol.
7 N
o.1
, W
inte
r 2012
33 Viral hepatitis and HIV infection among injection
drug users in a central Iranian City
Sofian M1, Aghakhani A,
Banifazl M, Azadmanesh K,
Farazi AA, McFarland W,
Ramezani A, A Eslamifar
J Addict Med. ISI
2013
2012
Dec
;6(4
):292
-6
Curriculum Vitae Dr. Ali Eslamifar
10
34 No Evidence of the Th1 to Th2 Cytokine Shift
during the Course of HIV Infection
Safyeh Soufian, Arezoo
Aghakhani, Minoo Mohraz,
Ali Mohammad Banifazl,
-, Zahra BolandEslamifar
Ghamat, Akbar Khadem-
Sadeghand Amitis Ramezani2
IRANIAN JOURNAL OF PATHOLOGY ISI
2012
Vol.
7 N
o.2
, S
pri
ng
2012
35
Seroprevalence of IgG Antibodies against
Bordetella pertussis in Different Age Groups in
Tehran, Iran
, Amitis Ali Eslamifar1
Ramezani1, Mohammad
Banifazl2, Akbar Khadem-
Sadegh1, Arezoo Aghakhani1
Iranian Journal of Pathology ISI
2012
(2012)
7 (
3),
171 -
176
36
The Influence of Human Leukocyte Antigen and
IL-10 Gene Polymorphisms on Hepatitis B Virus
Outcome
Amitis Ramezani, Mohammad
Banifazl, Setareh Mamishi,
Ali , Masoomeh Sofian
, Arezoo AghakhaniEslamifar
Hepat Mon ISI
2012
2012;1
2(5
)
37 Viral Hepatitis and HIV Infection in Hemodialysis
Patients
Arezoo Aghakhani 1,
Ali Mohammad Banifazl 2,
1, Farrokhlagha Eslamifar
Ahmadi 3, Amitis Ramezani
Hepat Mon ISI
2012
2012;1
2(7
):463
-464
38 Efficacy of Eosin B as a New Antimalarial Drug in
a Murine Model
Zahra Zamani,1 Alireza Sadeghi
Tafreshi,2 Hossein
Nahrevanian,3 Behzad Lame-
Rad,2 Fatemeh Pourfallah,1
4 Sedigheh Hossein Eslamifar,
Sadeghi,1 Farideh Vahabi,1
Ayda Iravani,1 and Mohammad
Arjmand1
Malaria Research and Treatment ISI
2012
10.1
155/2
012/3
8172
4
Curriculum Vitae Dr. Ali Eslamifar
11
39
Occult hepatitis B infection in different high risk
patients
Ali Ramezani, Banifazl,
, Masoomeh rEslamifa
Sofian . Arezoo Aghakhani
Hepat Mon ISI 2012
10.5
812/h
epat
mon
.7094
40
Serum Profile of T Helper 1 and T Helper 2
Cytokines in Hepatitis C Virus Infected Patients
Masoomeh Sofian, Arezoo
Aghakhani, Ali Asghar Farazi,
Ali Mohammad Banifazl 3,
, Niloofar Rashidi 2, Eslamifar
Akbar Khadem Sadegh 2,
Amitis Ramezan
Hepat Mon ISI
2012
10.5
812/h
epat
mon.6
156
41 Occult Hepatitis B Virus Infection in Hemodialysis
Patients: A Concept for Consideration
Arezoo Aghakhani, Mohammad
Ali Banifaz, Ali Akbar Velayati,
, Amitis RamezaniEslamifar
Ther Apher ISI
2012
Vol.
16, N
o. 4,
2012
42
Characterization of human herpes virus 8
genotypes in Kaposi's sarcoma patients in Tehran,
Iran
Kayhan Azadmanesh1, Zeinab
Sadat Norouzfar1,2, Amir
Sohrabi1,3, Zahra Safaie-
Naraghi4, Afshin Moradi5,
Parichehre Yaghmaei, Mona
Masoumeh Naraghi, Arash
Ali EslamifarArashkia,
Int J Mol Epidemiol Genet ISI
2012
2012:3
(2):
144
-152
43
Do the initial serum level changes of sCD26 have ability to
predict successful treatment with IFN- among naïve
chronic hepatitis B patients?
Mostafa Alavi-Moghaddama,
Seyed Alavianb, Aalaei-
Ali EslamiFarAndabilib,
Vaccine ISI
2011
29 (
2011)
9093–
9097
Curriculum Vitae Dr. Ali Eslamifar
12
44 Serological pattern of anti-HBc alone infers occult
hepatitis B virus infection in high-risk individuals in Iran
Amitis Ramezani, Mohammad
, Arezoo Ali EslamifarBanifazl,
Aghakhani
J Infect Dev Ctries ISI 2011
4(1
0):
658-6
61
45 Association between Human Papillomavirus Infection and
Risk of Prostate Cancer
Amitis Ramezani, Mohammad
, Arezoo Ali EslamifarBanifazl,
Aghakhani
Iranian Journal of Pathology ISI
2011
6 (
1),
3 -
7
46
Persistence of antibody to hepatitis B surface antigen
among vaccinated children in a low hepatitis B virus
endemic area
Arezoo Aghakhani, Mohammad
Banifazl, Nabiallah Izadi, Willi
McFarland, Masoomeh Sofi an,
Akbar Khadem-Sadegh, Zahra
Pournasiri, Maryam Foroughi,
, Amitis Ali Eslamifar
Ramezani
World J Pediatr ISI
2011
Vol
7 N
o 4
N
ovem
ber
15, 2011
47 Isolation of Cupriavidus Metallidurans from Razor Blade during Paraffin Embedded Tissue Sectioning
Sohrabi A, Norouzfar ZS,
, Arashkia A ,Eslamifar A
Azadmanesh K
Int J Mol Epidemiol Genet ISI
2011
2012:3
(2):
144
-152
48
In Silico Analysis of Six Known Leishmania major
Antigens and In Vitro Evaluation of Specific
Epitopes Eliciting HLA-A2 Restricted CD8 T Cell
Response
Negar Seyed1, Farnaz
Zahedifard1, Shima Safaiyan1,
Elham Gholami1, Fatemeh
Doustdari1, Maryam Mirzaei3,
Nasir Saeedi Eslami, Akbar
Ali Eslami Khadem Sadegh,
, Iraj Sharifi, Sima Rafati1far
Int J Mol Epidemiol Genet ISI
2011
2012:3
(2):
144
-152
Curriculum Vitae Dr. Ali Eslamifar
13
49 Comparison of QuantiFERON TB-G-test to TST for
detecting latent tuberculosis infection in a high-incidence
area containing BCG-vaccinated population
. Amina Kariminia, Zarin
Sharifnia, Aghakhani, Banifazl ,
Mahboob Ali Eslamifar,
Hazrati and Amitis Ramezani
Journal of Evaluation in Clinical Practice ISI
2010
15 (
2009)
148–
151
50 Assessing subtype and drug-resistance-associated
mutations among antiretroviral-treated HIV-infected
patients
Rasool Hamkara, Minoo
Mohrazb, Shima Lorestanic,
Arezoo Aghakhanid, Hong-Ha
M. Truonge, Willi McFarlande,
Ali Mohammad Banifazlf,
Maryam Foroughib, , amifarEsl
Atessa Pakfetratg and Amitis
Ramezanid
AIDS ISI 2
010
Vol
24 (
suppl
2)
51 Occult Hepatitis B Virus Infection in Hemodialysis
PatientsWith Isolated Hepatitis B Core Antibody: A
Multicenter Study
Arezoo Aghakhani,1
Mohammad Banifazl, Ebrahim
, , Ali EslamifarKalantar
Farrokhlagha Ahmadi, Effat
Razeghi,Shahnaz Atabak,
Manouchehr Amini, Akbar
Khadem-Sadegh, and Amitis
Ramezani1
Ther Apher Dial ISI
2010
Vol.
14, N
o. 3
52 Lack of occult hepatitis B virus infection among blood
donors with isolated hepatitis B core antibody living in an
HBV low prevalence region of Iran
Masoomeh Sofian , Arezoo
Aghakhani , Nabiallah Izadi ,
Mohammad Banifazl , Ebrahim
, Ali EslamifarKalantar ,
Amitis Ramezani
International Journal of Infectious Diseases ISI
2010
14 (
2010)
e308
–e3
10
Curriculum Vitae Dr. Ali Eslamifar
14
53 Surface gene mutations of hepatitis B virus among high-
risk patients with occult hepatitis B virus infection
Rasool Hamkara, Arezoo
Aghakhanib, Safyeh Soufianc,
Mohammad Banifazld, Nastaran
Ghavamia, Mahsa Nadria,
Masoomeh Sofiane,
Farrokhlagha Ahmadia, Effat
, Amitis Ali EslamifarRazeghia,
Ramezanib
Diagnostic Microbiology and Infectious Disease
ISI
2010
66 (
2010)
285
–291
54 Effect of Matricaria chamomilla L. flower essential oil on the growth
and ultrastructure of Aspergillus niger van Tieghem,
Marziyeh Tolouee , Soheil
, Ali Alinezhad , Reza Saberi b
, Seyed Javad Zad , Eslamifar
Kamkar Jaimand , Jaleh Taeb ,
ohammad-Bagher Rezaee ,
Masanobu Kawachi , Masoomeh
Shams-Ghahfarokhi, Mehdi
Razzaghi-Abyaneh
Journal of Food Microbiology ISI
2010
139 (
2010)
127
–133
55 Seroe pidemiology of hepatitis Avirus in children of
different gegroupsin Tehran,Iran: Implications for
healthpolicy
Masoomeh Sofian
ArezooAghakhani , Ali-
AsgharFarazi , Mohammad
Banifazl , GelavizhEtemadi ,
SaeedAzad-Armaki, Abolhassan
Ziazarifi, ZohrehAbhari,
Akbar Sadegh, AliEslamifar,
NabiallahIzadi, mitis Ramezani
Travel Medicine and Infectious Disease ISI
2010
(2010)
8, 176e1
79
56 In vitro Co-Culture of Human Skin Keratinocytes and
Fibroblasts on a Biocompatible and Biodegradable
Scaffold
Seyed Ramin Pajoum Shariati
&, Mohammad Ali Shokrgozar,
Ali Manouchehr Vossoughi and
Eslamifar
Iranian Biomedical Journal ISI
2009
13 (
3):
169
-177
Curriculum Vitae Dr. Ali Eslamifar
15
57 Hepatitis B virus genotype in Iranian patients with
hepatocellular carcinoma
Arezoo Aghakhani, Rasool
Ali Hamkar, Nastaran Zamani,
Mohammad Eslamifar,
Banifazl, Alireza Saadat,
Masoomeh Sofian, Ladan Adibi,
Nemat Irani, Matin Mehryar,
Hassan Mohammad Hosseini
Akbari , Seyed Mohammad
Javad Purkhayat , Amitis
Ramezani
International Journal of Infectious Diseases ISI
2009
13, 685—
689, 2009
58 Proteinuria Is Reduced by Inhibition of Inducible Nitric
Oxide Synthase in Rat Renal Ischemia-Reperfusion Injury
M. Kadkhodaee, M.
Zahmatkesh, H.R. Sadeghipour,
J. Taeb, A. A. Eslamifar,
Shams, and M. Mahdavi-
Mazdeh
Transplantation Proceedings ISI
2009
41, 2907–2909
59 Fungistatic effects of optical brightener 220 against
Trichophyton tonsurans, Aspergillus fumigatus and
Candida albicans.
Sadeghi G, Khaksar AA, Bassiri
A, Jahromi S, Amirkhani
A, Ajdary S, Katiraee Eslamifar
F, Taeb J, Paskiabi FA, Sayyah
M.
J Dermatolog Treat. ISI
2009
20(2
):120
-3
60 Comparison of QuantiFERON TB-G-test to TST for detecting latent tuberculosis infection in a high-
incidence area containing BCG -vaccinated population.
Kariminia A, Sharifnia Z,
Aghakhani A, Banifazl M,
Hazrati M, Eslamifar A,
Ramezani A.
J Eval Clin Pract. ISI
2009
Feb
;15(1
):148
-51
Curriculum Vitae Dr. Ali Eslamifar
16
61 HLA-A *3303* and *3301 predispose patients to persistent hepatitis B infection.
Ramezani A, Aghakhani A,
Kalantar E, Banifazl M,
, Velayati AAEslamifar A
J Gastrointestin Liver Dis ISI
2009
8(1
):117
-8
62 Frequency of isolated hepatitis B core antibody in HIV-hepatitis C virus co-infected individuals.
Ramezani A, Mohraz M,
Aghakhani A, Banifazl M,
Sadegh -, KhademEslamifar A
A, Velayati AA.
Int J STD AIDS. ISI
2009
May
;20(5
):336
-8
63 In vitro co-culture of human skin keratinocytes and fibroblasts on a biocompatible and biodegradable
scaffold.
Pajoum Shariati SR, Shokrgozar MA,
Vossoughi M, Eslamifar A. Iran Biomed J. ISI
2009
Jul;
13(3
):169
-77
64 Intra/extracellular biosynthesis of silver nanoparticles
by an autochthonous strain of Proteus mirabilis isolated from photographic waste.
Samadi N, Golkaran D, Eslamifar A,
Jamalifar H, azeli MR, Mohseni FA.
J Biomed Nanotechnol ISI
2009
Jun;5
(3):
247
-53.
65
Cytotoxic effect of drugs eluted from
polymethylmethacrylate on stromal giant-cell tumour cells
D. Gouran Savadkoohi,
P. Sadeghipour,H. Attarian,
S. Sardari,A. Eslamifar,
M. A. Shokrgozar
The Journal of Bone & Joint ISI
2008
VO
L. 90-B
, N
o. 7,
JUL
Y 2
008
Curriculum Vitae Dr. Ali Eslamifar
17
65 Occult hepatitis B virus infection in HIV-infected patients with isolated hepatitis B core antibody.
zadmanesh K, Mohraz M,
Aghakhani A, Edalat R, Jam S,
Banifazl M, A, Eslamifar
Moradmand-Badie B, Ramezani
A.
Intervirology. ISI 2008
51(4
):270
-4.
66 Frequency of hepatitis G virus infection among HIV
positive subjects with parenteral and sexual exposure.
Ramezani A, Mohraz M,
Vahabpour R, Jam S, Banifazl
A, Mahboudi F, EslamifarM,
Aghakhani A, Edalat R, Hekmat
S.
J Gastrointestin Liver Dis. ISI
2008
Sep
;17(3
):269
-72.
67 Frequency and genotype of GB virus C among Iranian patients infected with HIV.
Hekmat S, Mohraz M,
Vahabpour R, Jam S, Bahramali
G, Banifazl M, Aghakhani A,
oudi F, , MahbA Eslamifar
Edalat R, Ramezani A.
J Med Virol ISI
2008
Nov;8
0(1
1):
1941-
6
68 Association of human leukocyte antigen polymorphism with outcomes of hepatitis B virus infection.
Ramezani A, Hasanjani Roshan
, A EslamifarMR, Kalantar E,
Banifazl M, Taeb J, Aghakhani
A, Gachkar L, Velayati AA.
J Gastroenterol Hepatol. ISI
2008
Nov;2
3(1
1):
1716
-21
69 Cytotoxic effect of drugs eluted from
polymethylmethacrylate on stromal giant-cell tumour cells: an in vitro study.
Savadkoohi DG, Sadeghipour P,
EslamifarAttarian H, Sardari S,
A, Shokrgozar MA.
J Bone Joint Surg Br. ISI
2008
Jul;
90(7
):973
-9
Curriculum Vitae Dr. Ali Eslamifar
18
70 Frequency and associated factors of proteinuria in Iranian HIV-positive patients.
amezani A, Mohraz M, Banifazl
M, Jam S, Gachkar L, Yaghmaie
A, Zadsar M, EslamifarF,
Kalantar N, Nemati K, Haghighi
M, Rezaie M, Aghakhani A.
Int J Infect Dis ISI 2008
Sep
;12(5
):490
-4.
71 Persistence of hepatitis B vaccine immunity in hemodialysis patients.
Ramezani A, Velayati AA,
, Banifazl M, A Eslamifar
Ahmadi F, Maziar S, Razeghi E,
Kalantar E, Amirkhani A,
Aghakhani A.
Ther Apher Dial. ISI
2008
Apr;
12(2
):143
-6
72 Animal bites in Tehran, Iran.
, Ramezani A, A slamifar
Razzaghi-Abyaneh M, Fallahian
V, Mashayekhi P, Hazrati M,
Askari T, Fayaz A, Aghakhani
A.
Arch Iran Med. ISI
2008
Mar
;11(2
):200
-2.
73 Frequency and Identification of Fungal Strains in Patients
with Chronic Rhinosinusitis
Ali Eslamifar1, Mehdi Razzaghi-
Abyaneh2, Mohsen Vazir- ezami3,
Habibollah Moghadasi3,
Amitis Ramezani1, Masoomeh Shams-
Ghahfarokhi4, Ali hameneh5,
Mohammad Ali
Shokrgozar6, Ali Akbar mir-
Zargar7, Zahra Deljoodokht1,
Arezoo Aghakhani1
Iranian Journal of Pathology ISI
2008
(2008)3 (3), 135 -
139
74 High Blood Mercury Levels in Iranian Infants:A Cause for
Concern
Amitis RamezaniAli Eslamifar Latif
Gachkar1, Zahra Pournasiri3,
MohammadBanifazl4, Arezoo
Aghakhani2, Mohammad Rabbani5,
Mohammad Amin Faghih5Soroush
Sardari6 , Ali Akbar Velayati7
Iranian Journal of Pathology ISI
2008
2008)3
(4),
186-
190
Curriculum Vitae Dr. Ali Eslamifar
19
75
Association Between HLA-A, B, DRB1 Alleles and
Susceptibility or Resistance to Chronic Hepatitis B
A. Ramezani · M. R. Hasanjani Roshan ·
E. Kalantar · A. Eslamifar · M. Mohraz ·
M. Banifazl · A. Aghakhani · J. Taeb · A.
A. Velayati
International Journal of Infectious Diseases ISI
2008
75
Long Term Immune Response to Hepatitis B Vaccine in
Haemodialysis Patients
A. Ramezani · A. Eslamifar · M. Mohraz
· M. Banifazl · F. Ahmadi · S. Maziar · E.
Razeghi · E. Kalantar · M. Hazrati · A.
Amirkhani · A. Aghakhani
nternational Journal of Infectious Diseases ISI
2008
77
Comparison of IFN-Gamma Assay and Tuberculin Skin
Test for Detecting Latent Tuberculosis Infection in BCG-
Vaccinated Population
A. Ramezani · A. Kariminia · M. Mohraz
· M. Banifaz · Z. Sharifnia · A. Eslamifar
· M. Hazrati · A. Aghakhani
International Journal of Infectious Diseases ISI
2008
78
Fungistatic effects of optical brightener 220 against
Trichophyton tonsurans, Aspergillus fumigatus and
Candida albicans
Golnar Sadeghi · Ali Asghar Khaksar ·
Shahindokht Bassiri Jahromi · Aref
Amirkhani · Ali Eslamifar · Soheila
Ajdary · Farzad Katiraee · Jaleh Taeb ·
Farnoosh Asghari Paskiabi · Mohammad
Sayyah
Journal of Dermatological
Treatment ISI
2008
20(2
):120
-3 · D
ecem
ber
2008
79 Anemia Prevalence and Related Factors in HIV-Infected
Patients: A Cohort Study
Amitis Ramezani1, Arezoo Aghakhani1,
Mohammad Reza Sharif2, Mohammad
Banifazl3,
Ali Eslamifar1, Ali Akbar Velayati4
Iranian Journal of Pathology
ISI
2008
(2008)3
(3),
125
- 128
Curriculum Vitae Dr. Ali Eslamifar
20
80 Efficacy and long-term immunogenicity of hepatitis B
vaccine in haemodialysis patients.
A, EslamifarA, amezani
Banifazl M, Ahmadi F, Maziar
S, Razeghi E, Kalantar E,
Amirkhani A, Aghakhani A.
Int J Clin Pract. ISI 2007
Mar
;63(3
):394
-7
81 Hepatitis G virus exposure in dialysis staff.
, Hamkar R, A Eslamifar
Ramezani A, Ahmadi F,
Gachkar L, Jalilvand S, Adibi L,
Khameneh A, Atabak S,
Ghadimi R, Aghakhani A.
Ther Apher Dial. ISI
2007
Oct
;11(5
):370
-4.
82 Hepatitis G virus exposure in dialysis patients.
, Hamkar R, A Eslamifar
Ramezani A, Ahmadi F,
Gachkar L, Jalilvand S, Adibi L,
Atabak S, Khameneh A,
Ghadimi R, Aghakhani A.
Int Urol Nephrol. ISI
2007
;39(4
):1257
-63
83 Risk factors for human brucellosis in Iran: a case-control
study.
Sofian M, Aghakhani A,
, Velayati AA, Banifazl M
Ramezani A., A Eslamifar
Int J Infect Dis ISI
2007
Mar
;12(2
):157
-61
84 Detection of hepatitis G virus envelope protein E2
antibody in blood donors.
Ramezani A, Gachkar L,
Khoshbaten M, A, Eslamifar
Jalilvand S, Adibi L, Salimi V,
Hamkar R.
Int J Infect Dis. ISI
2007
Jan;1
2(1
):57
-61.
Curriculum Vitae Dr. Ali Eslamifar
21
85 Antimicrobial Susceptibility Pattern of Clinical Isolates
ofPseudomonas Aeruginosa in a Pediatric Hospital
Sara Jam1, Duman Sabzevari1, Arezoo
Aghakhani2, Ali Eslamifar2Mohammad
Banifazl3, Amitis Ramezani2
Iranian Journal of Pathology ISI
2007
(2007)2
(4),
144
-148
86 Metabolic Abnormalities in HIV-Positive Patients
Receiving Highly Active Antiretroviral Therapy
Amitis Ramezani1, Minoo Mohraz2,
Mohammad Banifazl3, Latif Gachkar4,
Sara Jam2, Ali Eslamifar1,
Farhad Yaghmaie5, Kambiz Nemati6,
Arezoo Aghakhani1
Iranian Journal of Pathology
2007
(2007)2
(4),
154
-158
87 ultrastructural evidences of growth inhibitory effects of a
novel biocide, Akacid(plus), on an aflatoxigenic
Aspergillus parasiticus.
Razzaghi-Abyaneh M, Shams-
Ghahfarokhi M, Kawachi M,
A, Schmidt OJ, Eslamifar
Schmidt A, Allameh A,
Yoshinari
Toxicon. ISI
2006
15;4
8(8
):1075
-82.
88 Cytosine deaminase producing Clostridium may be used in
detection of tumors.
Tirandaz H, Salehi-Najafabadi
EslamifarA, Med Hypotheses. ISI
2006
67(5
):1257
-8
89 Inhibitory effects of Akacid (plus) on growth and aflatoxin
production by Aspergillus parasiticus.
Razzaghi-Abyaneh M, Shams-
A, EslamifarGhahfarokhi M,
Schmidt OJ, Gharebaghi R,
Karimian M, Naseri A, Sheikhi
M.
Mycopathologia ISI
2006
Apr;
161(4
):245
-9
Curriculum Vitae Dr. Ali Eslamifar
22
90 Amygdala adenosine A1 receptors have no anticonvulsant
effect on piriform cortex-kindled seizures in rat.
Shahabi P, Mirnajafi-Zadeh J,
Fathollahi Y, Hoseinmardi N,
A. far-EslamiRezvani ME,
Can J Physiol Pharmacol ISI
2006
Aug-S
ep;8
4(8
-9):
913
-21.
91 Antiepileptogenic and anticonvulsant activity of
interleukin-1 beta in amygdala-kindled rats.
Sayyah M, Beheshti S,
A, far-EslamiShokrgozar MA,
Deljoo Z, Khabiri AR, Haeri
Rohani A.
Exp Neurol ISI
2005
Jan;1
91(1
):145
-53.
1 Occult HCV infection in hemodialysis patients with
elevated liver enzymes
Ramezani A, Eslamifar A
, Banifazl M2, Keyvani H,
Razeghi E, Ahmadi F, Amini M, Gachkar
L, Bavand AAghakhani
Arak Medical University Journal ISC
1392
201 4
, 16 -
80
34-4
0
2
Study on the Role of Alternaria alternata in the Etiology of
Allergic Asthma in Patients Admitted to Loghman
Hospital by using the Skin Prick Test and Solid-phase
Immunoassay
Fardis Teifoori , Masoomeh Shams-
Ghahfarokhi , Ali Eslamifar ,
Maryamossadat Moinazad-Tehrani ,
Parisa Mashayekhi , Mehdi Razzaghi-
Abyaneh
Modarres Journal of Medical Sciences
ISC
1392
16(2
) : 1-
12
3 Interleukin-10 Gene Promoter Polymorphisms and
Hepatitis B Virus Infection Outcome
Kalantar E, Ramezani A , Hosseini S,
Aghakhani A, Zarin Far N, Banifazl M ,
Deiry G, Roeei A, Ariamand A, Gachkar
L, Eslamifar A, and Sofian M
Iranian Journal of Infectious Diseases
and Tropical Medicine ISC
1391
1680-0
192
4 Seroepidemiology of Hepatitis E Virus Infection in HIV
Infected Patients
Eslamifar A, Aghakhani A, Mohraz
M,Banifazl M, Foroughi M, Sharif MR
,Ansari F, Bolandghamat Z, and
Ramezani A
Iranian Journal of Infectious Diseases
and Tropical Medicine ISC
1391
17, 5
9, 3
3-
36
Curriculum Vitae Dr. Ali Eslamifar
23
5
Epidemiological characteristics of animal bite cases
referred to treatment, rabies Pasteur Institute of Iran and
compare them in the 3-1372 and 8-1387 in Tehran.
Ahmad Fayaz, Vida Fallahiyan, Ali
Eslamifar
Medical research Journal
ISC
1390
35, 3
, 161
6 Frequency of Occult Hepatitis B Virus Infection in
Injection Drug Users
Ramezani A, Azadmanesh K, Aghakhani
A, Banifazl M, Farazi AA, Eslamifar A,
Edalat R, Izadi NA, Mahdaviani F and
Sofian M
Iranian Journal of Infectious Diseases
and Tropical Medicine ISC
1389
15, 4
8. 1
7
7 Involvement of Human Papillomavirus Infection in
Prostate Carcinoma
Hamkar R, Parvin M, Ghavami N,
Ramezani A, Nadri M, Banifazl M,
Pakfetrat A, Eslamifar A and Aghakhani
Iranian Journal of Infectious Diseases
and Tropical Medicine ISC
1389
15, 4
8. 1
7
8
Protozoa Cryptosporidium proliferation in Balb / c mice
and C76bl / 6 with suppressed immune Modeling of
Cryptosporidiosis in Immunodeficiency
sein Nahrevanian, Leila Abedinzadeh,
Karamollah Ghasemi, Ali Eslamifar,
Soheila Ajdari, Behzad Esfandiari,
Sadegh Rahbari, Marzieh Ezzati
Mirhashemi
Research Journal ISC
1389
15, 1
, 73
9 Seroprevalence of Bordetella Pertussis Antibodies in
Different Age Groups
Eslamifar A, Aghakhani A, Banifazl M,
Gachkar L, Khadem-Sadegh A,
Ramezani A
Iranian Journal of Infectious Diseases
and Tropical Medicine ISC
1389
15, 4
9, 1
7
10 Subtype Mutations and Related Drug-Resistance in Anti-
Retroviral Treated HIV Infected Patients
Ramezani A*, Hamkar R, Aghakhani A,
Lorestani SH, Banifazl M, Truong HH,
McFarland W, Foroughi M, Eslamifar A
and Mohraz M
Iranian Journal of Infectious Diseases
and Tropical Medicine ISC
1389
15, 5
0, 2
2
11 The prevalence of HHV-8 Kappes sarcoma in Iran by
Nested PCR
Zeinab osadat Nourozfar, Zahra Safai,
Amir Sohrabi, Afshin Moradi, Ali
Eslamifar
Nanotechnology Research microbial
Islamic Azad University
ISC
1389
2, 6
, 25
Curriculum Vitae Dr. Ali Eslamifar
24
12 Genetic variability of the S gene of hepatitis B virus
among High Risk Patients with Occult HBV Infection
Ramezani A, Hamkar R, Soufian S,
Banifazl M, Izadi N, Ghavami N, Sofian
M, Nazem H, Nadri M, Ahmadi F,
Razeghi E, Eslamifar A, and Aghakhani
Iranian Journal of Infectious Diseases
and Tropical Medicine ISC
1389
14, 4
7
13 Persistence of Anti-HBs Antibody in HBV Vaccinated
Children in a Low Endemic Area for HBV
Nabiallah Izadi NA, Arezoo Aghakhani
A, Mohammad Banifazl M, Masoomeh
Sofian M, Fatemeh sadat Mahdaviani F,
Ali Eslamifar A , Akbar Khadem-
Sadegh A, and Amitis Ramezani A
Iranian Journal of Infectious Diseases
and Tropical Medicine ISC
1389
14, 4
7
14 Association of Polymorphism of HLA-DRB1*13 and
HLA-A*33 Alleles with Outcome of Hepatitis B Virus
Infection
Velayati AA, Aghakhani A, Banifazl M,
, Khademi Z Eslamifar AKalantar E,
and Ramezani A
Iranian Journal of Infectious Diseases
and Tropical Medicine ISC
1388
14, 4
6
15 Seroepidemiology of Hepatitis A Virus in Children
Residing in Tehran
Ramezani A, Sofian M, Banifazl M,
Farazi AA, Etemadi G, Azad-Armaki S,
, Eslamifar A,Ziazarifi AH, Abhari Z
Gachkar L, Khadem-Sadegh A and
Aghakhani A
Iranian Journal of Infectious Diseases
and Tropical Medicine ISC
1388
14, 4
6
16 Isolated Anti-HBc in HIV- HCV Co-infected Patients Ramezani A, Aghakhani A, Banifazl M,
Eslamifar A, Mohraz M
Iranian Journal of Infectious Diseases
and Tropical Medicine ISC
1388
14, 4
5
17 Prevalence of Hepatitis G Virus in the Sera of HIV
Infected Patients with Parenteral and Sexual Exposure , Eslamifar ARamezani A, Banifazl M,
Gachkar L, Aghakhani A
Iranian Journal of Infectious Diseases
and Tropical Medicine ISC
1388
14, 4
5
18 Occult Hepatitis B Virus Infection among Blood Donors in
Arak
Masoomeh Sofian, Nabiallah Izadi,
Arezoo Aghakhani, Mohammad
Ali Banifazl, Ebrahim Kalantar,
Amitis Ramezani and Eslamifar
Iranian Journal of Infectious Diseases
and Tropical Medicine ISC
1388
14, 4
5
Curriculum Vitae Dr. Ali Eslamifar
25
19 Occult hepatitis B virus infection in hemodialysis patients
amezani A, Banifazl M, Kalantar E,
, Eslamifar AAhmadi F, Razeghi E,
Atabak SH, Amini M, Gachkar L,
Khadem-Sadegh A, and Aghakhani A
Iranian Journal of Infectious Diseases
and Tropical Medicine ISC
1388
14, 4
5
20 Making nanocomposite chitosan / polyvinyl alcohol
carbon nanotubes to nerve regeneration
Fatemeh Mottaghitalab2 ; Vahid
Ali ; 1Mehdi Farrokhi; 3Mottaghitalab
Mohammad Ali Shokrgozar 4slamifarE
MODARES
JOURNAL OF
MEDICAL
SCIENCES
(PATHOBIOLO
GY)
ISC
1388
12, 4
, 59
21 valuation of chitosan/poly (vinyl alcohol) nano-composite
biocompatibility for neural cells proliferation
Mohammad Ali Shokrgozar 1Fatemeh
Mottaghitalab2 ; Vahid Mottaghitalab3 ; 4
Ali Eslamifar; 1Mehdi Farrokhi
Pathobiology Research
ISC
1388
Volu
me
12, Issu
e 3
22 Occult Hepatitis B Virus Infection in HIV Infected
Patients
Ramezani A, Rasoolinejad M, Banifazl
, Gachkar Eslamifar AM, Aghakhani A,
L, and Mohraz M
Iranian Journal of Infectious Diseases
and Tropical Medicine ISC
1387
13, 4
6
23 Asymptomatic Proteinuria in HIV-Infected Outpatients Aghakhani A, Mohraz M, Banifazl M,
, Gachkar L, Nemati Eslamifar AJam S,
K and Ramezani A
Iranian Journal of Infectious Diseases
and Tropical Medicine ISC
1387
13, 4
2, 9
24 Hepatitis B Virus Genotype in Iranian Hepatocellular
Carcinoma patients
Hamkar R , Zamani N, Ramezani A,
, Banifazl M, Sofian M, Eslamifar A
Adibi L, saadat AR , Irani N, Mehryar M,
Taeb J, Deljoodokht Z, and Aghakhani A
Iranian Journal of Infectious Diseases
and Tropical Medicine ISC
1387
13, 4
1, 2
2
Curriculum Vitae Dr. Ali Eslamifar
26
25 Prevalence and Genotype of Hepatitis G virus infection in
HIV Positive Patients
Ramezani A, Hekmat S, Jam S,
Vahabpour R, Bahramali G, Aghakhani
, Banifazl M, Gachkar L, Eslamifar AA,
anMohraz M
Iranian Journal of Infectious Diseases
and Tropical Medicine ISC
1387
13, 4
1. 7
26 Blood Gamma Interferon Assay for Detection of Latent
Tuberculosis Infection: Potential to Replace the Mantoux
Skin Test
Kariminia A, Sharifnia Z, Aghakhani A,
, Deljoodokht Eslamifar ABanifazl M,
Z, Hazrati M, and Ramezani A
Iranian Journal of Infectious Diseases
and Tropical Medicine ISC
1387
13, 4
0, 1
27 Long-Term Immunity of Hepatitis B Vaccine in Patients
Undergoin Hemodialysis
, , Eslamifar ARamezani A, Aghakhani A
Banifazl M, Gachkar L, Taeb J, Deljoo Z,
Kalantar E, and Velayati AA
Iranian Journal of Infectious Diseases
and Tropical Medicine ISC
1387
13,4
0,2
1
28 Reducing proteinuria resulting from ischemia - reperfusion
by a selective inhibitor of nitric oxide synthase in rat
kidneys
Maryam Zahmatkesh, Mehdi kadkhodai,
ali EslamifarFereshteh Golab,
Infectious Diseases and Tropical Medicine
Journal ISC
1387
2.3
7
29 Blood mercury levels in infants receiving vaccines
containing Thimerosal. Aghakhani A, Eslamifar A,Ramezani A,
Infectious Diseases and Tropical Medicine
Journal ISC
1386
12(3
8):1
7-
20
30 Eosinophilic gastroenteritis: A case report Aghakhani Eslamifar A,Soofian M,….
A, Ramezani A.
Infectious Diseases and Tropical Medicine
Journal ISC
1386
12(3
8):6
3-
6
Curriculum Vitae Dr. Ali Eslamifar
27
31 Natural YMDD mutants in chronic B hepatitis. . Eslamifar ARamezani A, Aghakhani A
Infectious Diseases and Tropical Medicine
Journal ISC
1386
12(3
7): 1
-6
32 Prevalence of Hepatitis G virus exposure in blood donors. Eslamifar ARamezani A, Gachkar L,
Infectious Diseases and Tropical Medicine
Journal ISC
1386
37(1
2).
33
The role of galanin receptors in antiن
convulsant effect of low frequency
stimulations on acquisition of perfor
ant path kindled seizures in rats
Mehdi Sadegh, Javad Mirnajafi-
Zadeh,Mohammad Javan, Yaghoub
Fathollahi, ohammad Mohammad-Zadeh,
li Jahanshahi, Ali Eslamifar, Zahra Deljo
Physiology and
Pharmacology
ISC
1386
11(1
), 10 - 1
8
34 Determination of Human Papillomavirus genotypes in
cervical cancer speciemens in Yazd province Mahmoodi SMM, Hamkar R,
Eslamifar A…
Infectious Diseases and Tropical Medicine
Journal ISC
1385
37(1
2)(
35 Detection of Hepatitis G Virus Envelope Protein E2
Antibody in Dialysis Staff
., Aghakhani A., Ramezani Eslamifar A
A., Hamkar R., Ahmadi F., Gachkar L.,
Atabak SH., Khameneh A., Ghadimi R.
and Velayati A.A
Infectious Diseases and Tropical Medicine
Journal ISC
1385
11,3
5
36 Demonstration of microbial biofilm in Ethmoidal sinus of
refractory chronic rhinosinusitis patients by SEM Eslamifar Adi Y, Naraghi M, Ami
The Iranian journal of Otorhinolaryngology ISC
1385
18(4
6):1
81
-4
37
Detection of High Risk Human Papillomaviruses in
Esophageal Squamous Cell Carcinoma by PCR and DNA
Sequencing.
., Aghakhani A. , Hamkar Eslamifar A
R., Ramezani A., Tirgari F., Frootan H.,
Mirmomen Sh., Gheini MH. ,
Deljoodookht Z., Taeb J
Infectious Diseases and Tropical Medicine
Journal ISC
1384
11(3
3): 1
-5
Curriculum Vitae Dr. Ali Eslamifar
28
38 Detection of Hepatitis G Virus Envelope Protein E2
Antibody in Dialysis Staff ni A., Aghakhani A. RamezaEslamifar A
Infectious Diseases and Tropical Medicine
Journal ISC
1384
11(3
5): 7
3-
79
39 Molecular epidemiology of clinical strains of enteococci
Faecium in Tehran hospitals
Ramezani A, Mohraz M, Feizabadi M,
Eslamifar Asgharzadeh A, Parastan R,
elayati AAliahmadi A, V A,
Infectious Diseases and Tropical Medicine
Journal ISC
1383
Vol. 1
0,
No. 3
1
40 Influence of electrical destruction of Amygdal on
convulsion due to , Eslamifar AShahabi P, Mirnajafi J,
Deljoo Z.
Physiology and Pharmacology Journal ISC
1383
Vol. 9
, No.
2
41 Study Epidemiology of animal bites in persons referred to
Institute Pasteur of Iran (Tehran province). , Nazgooie F,, Eslamifar ARamezani A
Falahian L, Hazrati M, Naseri M.R.
Infectious Diseases and Tropical Medicine
Journal ISC
1382
Vol. 9
, No.
27
42
Study vaccine includes thiomersal and relations with
neurodevelopment disorders in neonates and embryonic
periods.
Hazrati M. Eslamifar A,Ramezani A, Infectious Diseases
and Tropical Medicine Journal
ISC
1382
Vol. 9
, No.
26.
43 Epidemiology of animal rabies in Tehran province. A, Eslami N, A, EslamifarRamezani Nazgooie F.
Infectious Diseases and Tropical Medicine
Journal ISC
1382
Vol. 9
, No.
25
44 Survey situation of nosocomial infection due to enterococci in Tehran hospitals.
amezani A, Mohraz M, Asadi S, Eslamifar A.Nazgooie F,
Infectious Diseases and Tropical Medicine
Journal ISC
1381
19, 1
1
Curriculum Vitae Dr. Ali Eslamifar
29
Seminars and academic conferences
Cod
Title Authors conferences Year Place
1 Using Confocal microscopy in clinical research Ali Eslamifar, Saeid Mahmoudi
The 2 nd congress of Cytotechnology
And Its Applications
2015 Iran
2 Molecular epidemiology of human parvovirus B19 in a cohort of
HIV-infected patients
Amitis Ramezani, Kayhan
Azadmanesh Kazemimanesh, M
A Foroghi,, Mohammad Banifazl,
Arezoo Aghakhani, M ,arEslamif
Mohraz
ESCMID 2015 Denmark
3 No evidence of occult hepatitis C virus infection among renal
transplant candidates
A. Eslamifar, A. Ramezani
S. Ossareh, M. Banifazl, H.
Keyvani, A. Aghakhani
ESCMID 2015 Denmark
4 Interleukine-17 and TGF-beta levels in patients with acute
brucellosis and its relation with treatment
M. Sofian, A. Ramezani*M.
Banifazl, A. Eslamifar, S. Cherei,
A. Cherei, A. Aghakhani
ESCMID 2015 Denmark
5 BK viraemia in patients with chronic renal disease undergoing
haemodialysis and peritoneal dialysis
A.Ramezani*A. Sharif, M.R.
Sharif, A. Aghakhani, R. Hamkar,
N. Ghavami, A. Eslamifar, M.
Banifaz
ESCMID 2015 Denmark
6 Occult hepatitis B virus infection in HIVinfected patients after
HBV vaccination
A. Ramezani* M. Mohraz,
Aghasadeghi, M. Banifazl, R.
Vahabpour, M. Foroughi, A.
Eslamifar, A. Aghakhani
ESCMID 2015 Denmark
7 Using confocal microscopy in the
diagnosis of pathology
Mahmoudi. saeidAli Eslamifar
Samaneh saffar nazanin sharifi .
mehrad eslamifar. mohsen
Congress of Pathology
2015 Iran
Curriculum Vitae Dr. Ali Eslamifar
30
8 Occult hepatitis C virus infection among Iranian haemodialysis
patients Amitis Ramezania Mohammad
Ali EslamifarBanifazlf hepatitis 2014 Iran
9 Seroepidemiology of Hepatitis E Virus infection in Blood Donors
of Central Province of Iran
Hassan Ehteram, Amitis Ramezani
, Masoomeh Sofian Ali Eslamifar
Mohammad Banifazl, Parisa
Mashayekhi 5, Arezoo Aghakhani
Congress of Pathology
2013 Iran
10 No Evidence of Human Papillomavirus Infection in the Etiology of
Colon Adenocarcinamas and Adenomas
Arezoo Aghakhani1, Rasool
, Farahnaz Ali EslamifarHamkar,
Bidari Zerehpoosh3
Shahram Sabeti3, Nastaran
Ghavami2, Mohammad Banifazl4,
Amitis Ramezani1
Congress of Pathology
2013 Iran
11 Hematological Reference Ranges for Healthy Adult Males in the
Central province of Iran
Masoomeh Sofian1, Mandana
Aghakhani3, Mohammad Banifazl
Nader Zarinfar , Ali Eslamifar
Fatemeh Mahdaviani, Ramezani3
Congress of Pathology
2013 Iran
12 Immunogenicity of one Intradermal or Intramuscular Booster
Vaccination Dose in HIV Infected individuals who failed to
Standard Vaccination
Masoomeh Sofian1, Alireza
Janbakhsh2, Aghakhani3*,
Banifazl4 Maryam Gol-
Ali Eslamifar3,Mohammadi5,
Mahdavian2
Congress of Pathology
2013 Iran
13 Immunity to Diphtheria and Tetanus among Blood Donors in a
Central Iranian City
1, Amitis Ramezani Ali Eslamifar
1, Mohammad Banifazl 2,
Masoomeh Sofian 3, Fatemeh-
Mahdaviani 4, Aghakhani
Congress of Pathology
2013 Iran
14 P931 Serum profile of T helper 1 and T helper 2 cytokines in
HCV-infected patients
Arezoo Aghakhani,1 Mohammad
Banifazl,2 Ali Akbar Velayati,3
,1 and Amitis Ali Eslamifar
Ramezani
ESCMID 2012 England
15 R2406 Reduction in interleukin-2 serum levels but lack of
evidence of the Th1 to Th2 cytokine shift during the course of HIV
infection
afyeh Soufian · Amitis Ramezani ·
Aghakhani · Mohammad Banifazl ·
· Minoo Mohraz Ali Eslamifar ESCMID 2012 England
Curriculum Vitae Dr. Ali Eslamifar
31
16 PP-045 Pathophysiology of cryptosporidiosis in
immunosuppressed Balb/c and C57bl/6 mice models
H. Nahrevanian, L. Abedinzadeh,
M. Amini, S. Eslamifar,A.
Naeimi 5 th DICID 2011 China
17 Follow up Hemodialysis Patients with Occult Hepatitis B Virus
Infection
, Ali EslamifarAmitis Ramezani,
Mohamad banifazel, Farrokhlagha
Ahmadi
iiccom 2013 Iran
18 Frequency of hepatitis D Virus Infection in HIV positive and
hemodiyalisis patients in Iran
Amitis Ramezani, Mohammad reza
Aghasadeghi, golnaz bahramali,
Arezoo Aghkhani, Mohammad
banifazl, Seyed Mehdi Sadat,
, Ali EslamifarMaryam Foroghi,
Seyed davar Siadat
iiccom 2011 Iran
19 Comparison of Brucella Induced epididymo or orchitis, with
Nonspecific Area for Brucellosis
Masomeh Sofiyan, Amitis
Ramezani, Arezoo Aghkhani,
Ali Mohammad banifazl,
Hossein Sarmadian, Ali Eslamifar,
akbar velayati
iiccom 2011 Iran
20 Tetanus and Diphtheria seroprevalence in HIV Infected patients
, Amitis Ramezani, Ali Eslamifar
Minoo Mohraz, Mohammad
banifazl, Maryam Foroghi Arezoo
Aghkhani,
iiccom 2011 Iran
21 Eroprevalence of human T-Cell Leukemia Virus Type 1 (HTLV-1)
and HTLV-2 Infection in HIV Infected patients
Amitis Ramezani, Arezoo
Aghkhani, Mohammad banifazl,
Ali Eslamifar,Maryam Foroghi,
Minoo Mohraz,
iiccom 2011 Iran
22 Serum Profile of T helper 1 and T helper 2 Cytokines in HCV
Infected patients
Amitis Ramezani, Masomeh Sofian
Arezoo Aghkhani, Ali Asghar
Ali Farazi Mohammad banifazl,
Ali Akbar Velayati Eslamifar,
iiccom 2011 Iran
23 Occult Hepatitis B Virus Infection in Hemodialysis Patients
Arezoo Aghkhani, Mohammad
Reza Aghasadeghi, Mohammad
Shahin Ali Eslamifar,banifazl,
ghasemi, Farrokhlagha Ahmadi
Amitis Ramezani, Ali
iiccom 2013 Iran
Curriculum Vitae Dr. Ali Eslamifar
32
24 Seroprevalence of Brucellosis Antibodies in blood Donors in
Central Province of Iran
Masomeh Sofiyan, Mehrnoosh
Sheikholeslami, Hossein
Sarmadian, Fatemeh Alsadat
Ali Mahdaviani, Arezoo Aghkhani,
orban Deiri Amitis Gh Eslamifar,
Ramezani,
iiccom 2013 Iran
25 prevalence of HIV, HCV and HBV Infections and Associated Risk
Factors among Injecting Drug User in Arak City
Masomeh Sofiyan, Arezoo
Aghkhani,Reyhaneh Amir Moezzi,
Nader Zarinfar, Mohammad
Amitis lamifarAli Esbanifazl,
Ramezani,
iiccom 2013 Iran
26 Importance of Family Members Screening of Cases with Acute
Brucellosis
Masomeh Sofiyan, Leila
Safaeipour, Arezoo Aghkhani,
Ali Mohammad banifazl ,
Ali Asghar Farazi, Eslamifar
Farshideh didgar,
iiccom 2013 Iran
27 Hepatitis E Virus co-Infection in HIV Infected patients
Amitis Ramezani Minoo Mohraz,
Mohammad Ali Eslamifar
banifazl ,Sara khorrami, Masomeh
Sofiyan, Arezoo Aghkhani
iiccom 2013 Iran
28 Mutations in the S gene region of hepatitis B virus in High Risk
Patients with Occult HBV Infection
Ramezani A, Aghakhani A,
and Eslamifar ASoufian S,
Banifazl M 20th ECCMID 2010 Australia
29 Distribution of pertussis antibodies among Iranian children of
different age groups.
A, Aghakhani A, Eslamifar
Banifazl M, Khadem-Sadegh A
and Ramezani A. 20th ECCMID 2010 Australia
30 The Role of Human Papillomavirus Infection in Prostate
Carcinoma
Aghakhani A, Hamkar R, Parvin
A, Banifazl M and EslamifarM,
Ramezani 14th ICID 2010 America
31 Frequency of isolated antibody to hepatitis B core antigen in HIV-
HCV coinfected individuals Ramezani A, Aghakhani A,
A, Banifazl M. Eslamifar 14th ICID 2010 America
Curriculum Vitae Dr. Ali Eslamifar
33
32 Association of polymorphism of HLA-DRB1 13 and HLA-A 33
alleles with outcome of hepatitis B virus infection. Ramezani A, Aghakhani A,
A, Banifazl Eslamifar 14th ICID 2010 America
33 No evidence of occult hepatitis B virus infection among anti-HBc-
positive blood donors in an area of low endemicity for HBV Ramezani A, ,Aghakhani A,
A, Banifazl M Eslamifar 14th ICID 2010 America
34 Frequency of occult hepatitis B virus infection in HIV infected
patients Ramezani A, Aghakhani A,
A, Banifazl M Eslamifar 14th ICID 2010 America
35 The epidemiology of tuberculosis in Arak city, Central province of
Iran from 1997- 2007 Ramezani A, Aghakhani A,
A, Banifazl M Eslamifar 14th ICID 2010 America
36 nti-HBs titers in vaccinated children and adolescents: Implication
for booster administration. Ramezani A, Aghakhani A,
A, Banifazl Eslamifar 14th ICID 2010 America
37 Prevalence of Occult Hepatitis B Infection in Iranian Injection
Drug Users Ramezani A, Banifazl M,
A, Aghakhani A Eslamifar 14th ICID 2010 America
38 Association of Human Papillomavirus and Breast Carcinoma. A, Ramezani A, Eslamifar
Banifazl M, Bidari F, Moradi A
and Aghakhani A.
19th Iranian
congress on
infectious diseases
and tropical
medicine
2010 Iran
39 Occult and chronic hepatitis B, hepatitis C, and HIV infections and
co-infections among injection drug users. Ramezani A, Sofian M, Aghakhani
.A, Banifazl M EslamifarA,
19th Iranian
congress on
infectious diseases
and tropical
medicine
2010 Iran
Curriculum Vitae Dr. Ali Eslamifar
34
40 Genotype characterization of hepatitis G virus isolates from Iranian
patients infected with human immunodeficiency virus. Ramezani A, Mohraz M,
A, EslamifarAghakhani A, 19th ECCMID 2009 Finland
41 Occult hepatitis B virus infection in ―anti-HBc alone‖
haemodialysis patients.
Ramezani A, Aghakhani A,
Mohraz M, Eslamifar A, Khadem-
Sadegh A,
Banifazl M.
19th ECCMID 2009 Finland
42 Predictive value of purified protein derivative in pulmonary
tuberculosis in a high BCG-vaccinated population
Sofian M, Ramezani A, Aghakhani
A, Eshrati B, Eslamifar A,
Banifazl 19th ECCMID 2009 Finland
43 Identification of hepatitis B virus genotype in patients with
hepatocellular carcinoma in Iran. Aghakhani A, Hamkar R,
Eslamifar ARamezani A 19th ECCMID 2009 Finland
44 Significance of Hepatitis B Core Antibody as the Only Marker of
Hepatitis B Virus Infection. Ramezani A, Mohraz M, Banifazl
M, Eslamifar A and Aghakhani
The 3rd Annual
Iranian Congress
on HIV/AIDS
2009 Iran
45 Frequency of isolated antibody to hepatitis B core antigen in
HIV- HCV coinfected individuals
Aghakhani A, Mohraz M, Banifazl
M, Eslamifar A, Khadem-Sadegh
A and
Ramezani A
The 3rd Annual
Iranian Congress
on HIV/AIDS
2009 Iran
46 Frequency of Occult Hepatitis B Virus Infection and its Surface
Mutants in HIV Positive Patients
Ramezani A, Mohraz M,
Aghakhani A, Banifazl M,
Eslamifar A Hamkar
The 3rd Annual
Iranian Congress
on HIV/AIDS
2009 Iran
47 Occult hepatitis B virus infection in blood donors with isolated
anti-HBc
Ramezani A, Sofian M, Aghakhani
A, Eslamifar A, Izadi N, Banifazl
M.
18th
Iranian congress on
infectious diseases
and tropical
medicine
2009 Iran
48 Association of Human Papillomavirus with Prostate Cancer Aghakhani A, Hamkar R, Parvin
M, Eslamifar A, Banifazl M,
Ramezani A
18th Iranian
congress on
infectious diseases
2009 Iran
Curriculum Vitae Dr. Ali Eslamifar
35
and tropical
medicine,
49 Seroepidemiology of pertussis antibodies among children of
different age groups.
Eslamifar A, Aghakhani A,
Banifazl M, Khadem-Sadegh A,
Ramezani A
18th Iranian
congress on
infectious diseases
and tropical
medicine
2009 Iran
50 Hepatitis B virus Surface Gene Mutations in High Risk Patients
with Occult HBV Infection
Ramezani A, Mohraz M, Hamkar
R, Aghakhani A, Eslamifar A,
Soufian S,
Banifazl M
18th Iranian
congress on
infectious diseases
and tropical
medicine
2009 Iran
51 Age specific seroprevalence of hepatitis A antibody: Implications
for health policy.
Ramezani A, Aghakhani A,
Eslamifar A, Khadem-Sadegh A,
Banifazl M.
18th Iranian
congress on
infectious diseases
and tropical
medicine
2009 Iran
52 Seroprevalence of hepatitis B surface antibody in children
subjected to the Expanded Programme on Immunization (EPI).
Ramezani A, Aghakhani A,
Eslamifar A, Khadem-Sadegh A,
Banifazl M.
18th Iranian
congress on
infectious diseases
and tropical
medicine
2009 Iran
53 Hepatitis G virus infection in patientsinfected with the human
immunodeficiency virus
Ramezani A, Mohraz M,
Vahabpour R, Eslamifar A,
Mahboudi F,
Aghakhani A, Edalat R, Hekmat S
13th ICID 2008 Malaysia
54 Association between HLA-A, B, DRB1 alleles and susceptibility
or resistance to chronic hepatitis B Ramezani A, Eslamifar ATaeb J,
Aghakhani A 13th ICID 2008 Malaysia
Curriculum Vitae Dr. Ali Eslamifar
36
55 Prevalence of Metabolic abnormalities in HIV-Infected Patients
Receiving Highly Active Antiretroviral Therapy and antiretroviral-
naive patients
Ramezani A, Mohraz MAghakhani
A, Eslamifar A 13th ICID 2008 Malaysia
56 Long term Immune response to hepatitis B vaccine in hemodialysis
patients Ramezani A, Eslamifar A, Mohraz
M,….. and Aghakhani 13th ICID 2008 Malaysia
57 Comparison of IFNgamma assay and Tuberculin Skin Test for
detecting latent tuberculosis infection in BCG-vaccinated
population.
Ramezani AEslamifar Aghakhani
A. 13th ICID 2008 Malaysia
58 The role of fungi in the etiology of chronic rhinosinusitis Eslamifar A, Aghakhani A
,Ramezani A
12th International
Congress of
Mycology
2008 Turkey
59 Genotype Characterization of Hepatitis B Virus Isolates from
Iranian Patients with Hepatocellular Carcinoma . Aghakhani A, Hamkar REslamifar
ARamezani A.
10th annual
congress of
pathology and 4th
annual
congress of Iranian
cancer association,
2008 Iran
60 Frequency of Fungi and Eosinophilic Granulocytes in Chronic
Rhinosinusitis . Eslamifar ARamezani Aghakhani
A
10th annual
congress of
pathology and 4th
annual
congress of Iranian
cancer association,
2008 Iran
61 Significance of Hepatitis B Core Antibody as the Only Marker of
Hepatitis B Virus Infection Ramezani A, Mohraz M, Banifazl
M, Eslamifar A and Aghakhani
17th Iranian
congress on
infectious diseases
and tropical
medicine
2008 Iran
Curriculum Vitae Dr. Ali Eslamifar
37
62 Genotype characterization of hepatitis G virus isolates from Iranian
patients infected with human immunodeficiency virus (HIV). Ramezani A, Mohraz MAghakhani
AEslamifar A and Velayati
17th Iranian
congress on
infectious diseases
and tropical
medicine
2008 Iran
63 Frequency of isolated antibody to hepatitis B core antigen in HIV-
HCV coinfected individuals
Ramezani A, Mohraz M,
Aghakhani A, Banifazl M,
Eslamifar, Khadem-
Sadegh A, Velayati AA
17th Iranian
congress on
infectious diseases
and tropical
medicine
2008 Iran
64 Association of polymorphism of HLA-DRB1*13 and HLA-A *33
alleles with outcome of hepatitis B virus infection. Ramezani A, Aghakhani
AEslamifar A
17th Iranian
congress on
infectious diseases
and tropical
medicine
2008 Iran
65 Frequency of occult hepatitis B virus infection in HIV infected
patients.
Ramezani A, Mohraz M,
Aghakhani A, Banifazl M,
Eslamifar A, Velayati
17th Iranian
congress on
infectious diseases
and tropical
medicine
2008 Iran
66 Occult hepatitis B virus infection in "anti-HBc alone" hemodialysis
patients.
Ramezani A, Aghakhani A,
Eslamifar, Khadem-Sadegh A,
Banifazl M.
17th Iranian
congress on
infectious diseases
and tropical
medicine
2008 Iran
67 Risk factors for human brucellosis in Iran: a case control study. M. Soofian, A. Ramezani, A.
Aghakhani, A. Eslamifar ECCMID-ICC 2007 Germany
Curriculum Vitae Dr. Ali Eslamifar
38
68 Prevalence of hepatitis G exposure in patients on chronic dialysis. Eslamifar A. ,Aghakhani A.
,Ramezani A
1st European
Congress of
Pathology
2007 Turkey
69 Performance of QuantiFERON TB-G Test for detecting latent
tuberculosis infection in BCG-vaccinated population.
A. Kariminia, Z. sharifnia, A.
Aghakhani, M. Banifazl , A.
Eslamifar,
M.Hazrati and A. Ramezani.
16th
Iranian congress on
infectious diseases
and tropical
medicine
2007 Iran
70 Persistence of Hepatitis B Vaccine Immunity in Hemodialysis
Patients A.Ramezani, A.Eslamifar......
A.Aghakhani.
16th Iranian
congress on
infectious diseases
and tropical
medicine
2007 Iran
71 Frequency of hepatitis B and hepatitis C virus infections in HIV
infected subjects A.Ramezani,M.Mohraz,....A.Agha
khani,.Eslamifar
16th Iranian
congress on
infectious diseases
and tropical
medicine
2007 Iran
72 Impact of antiretroviral treatment on lipid profile in HIV infected
patients A.Ramezani,M.Mohraz,....A.Agha
khani,.Eslamifar,
16th Iranian
congress on
infectious diseases
and tropical
medicine
2007 Iran
73 Anemia in HIVinfected patients receiving highly active
antiretroviral therapy A.Ramezani,M.Mohraz,....A.Agha
khani,.Eslamifar,.
16th Iranian
congress on
infectious diseases
and tropical
medicine
2007 Iran
Curriculum Vitae Dr. Ali Eslamifar
39
74 Influence of HLA class І and II alleles on the outcome of hepatitis
B virus infection.
A.Ramezani.MR Hasanjani
Roshan,...A.Eslamifar, Taeb, A.
Aghakhani
16th Iranian
congress on
infectious diseases
and tropical
medicine
2007 Iran
75 Detection of YMDD mutation in Iranian chronic hepatitis B
patients before lamivudine treatment. A.RamezaniA.Eslamifar and A.
Aghakhani.
9th annual congress
of pathology and
3rd annual
congress of Iranian
cancer
association
2007 Iran
76 Frequency of Human Papillomavirus Infection in Esophageal
Squamous Cell Carcinoma of Iranian patients. Esalamifar A, Aghakhani A,
Hamkar R, Ramezani
12th International
Congress on
Infectious
Diseases,
2006 France
77 Hepatitis G virus exposure in dialysis patients. Eslamifar A, Ramezani A....
Aghakhani
8th annual congress
of pathology and
2nd congress of
oncology
2006 Iran
78 Role of human papillomavirus infection in esophageal carcinoma Eslamifar A , Hamkar R,
Ramezani A.... Aghakhani A.
8th annual congress
of pathology and
2nd congress of
oncology
2006 Iran
79 Epidemiology of Animal Bites in Tehran. Eslamifar A, Aghakhani A,
Ramezani A,
15th Iranian
congress on
infectious diseases
and tropical
medicine
2006 Iran
Curriculum Vitae Dr. Ali Eslamifar
40
80 Hepatitis G virus(HGV) Exposure in Dialysis Staff Eslamifar A, Hamkar R,
Ramezani … Aghakhani
15th Iranian
congress on
infectious diseases
and tropical
medicine
2006 Iran
81 YMDD mutants in patients with chronic hepatitis B before
treatment are not selected by lamivudine. Ramezani A , Eslamifar A and
Aghakhani
15th Iranian
congress on
infectious diseases
and tropical
medicine
2006 Iran
82 Exposure to Hepatitis GB Virus in Patients on Maintenance
Hemodialysis. Eslamifar A, Hamkar R,
Ramezani … Aghakhani
15th Iranian
congress on
infectious diseases
and tropical
medicine
2006 Iran
83 Factors influencuing to hepatitis B virus vaccination in
hemodialysis patiens. Ramezani , Eslamifar A
XLIII ERA-EDTA
Congres 2006 England
84 Frequency of Hepatitis G infection among Iranian blood donors Ramezani A, Eslamifar A
12th international
congress on
infectious diseases
2006 Portugal
85 Assesment of blood mercury levels in infants exposed to vaccines
containing thiomersal Ramezani,Eslamifar A
2nd international
congress on
infectious and
tropical diseases
2006 Amman
86 Efficacy of hepatitis B vaccination schedule and comparing to
complete regimen hemodialysis patients of Iran Ramezani, Eslamifar A
12th
international
congress on
infectious diseases
2006 Portugal
Curriculum Vitae Dr. Ali Eslamifar
41
87 Frequency of hepatitis G infection among Iranian blood donors Gachkar L, Ramezani A,
Eslamifar A, Hamkar R,
Khoshbaten M, Hazrati
14th Congress
of Infectious
Disease
2005 Iran
88 Frequency of vancomycin resistant Enterococci faecium in
hospitals of Tehran.
Ramezani A, Mohraz M, Feiabadi
M, Banifazl M, Eslamifar A,
Velayati
14th Congress
of Infectious
Disease
2005 Iran
89 Factors influencing to hepatitis B vaccination response in
hemodialysis patients of Tehran (Iran). Ramezani A, Eslamifar A, Hazrati
Mb, Mohraz M
14th Congress
of Infectious
Disease
2005 Iran
90 Case report of skull plasmocytic granulom and study Efficacy of
electron microscopy on diagnosis. Eslamifar A
Congress of
Pathology 2004 Iran
91 Rates of scar failure in children vaccinated with BCG A, Heidari EslamifarRamezani A,
L, Hosseini H, Hazrati M
13th Congress of
Infectious
Diseases.
2004 Iran
92 Situation of MR vaccination on mass campaign project in persons
referred to Pasteur Institute of Iran.
A, Ramezani A, Eslamifar
Nazgooie F,Mafakheri M, Hosseini
Z Naseri M.
12th Congress of
Infectious Diseases 2003 Iran
Curriculum Vitae Dr. Ali Eslamifar
42
Research projects:
Title
Cod
Prevalence of human papillomavirus infection in patients with breast cancer and benign breast samples referred to Shohada hospital, and Imam
Luqman 1
Restoring blanket making nanofibers carrier Antidermatophytal terbinafine and evaluation of in vitro 2
Prevalence of human papillomavirus infection in patients with adenocarcinoma of the colon and colorectal adenomatous polyps admitted to
hospital in Mashhad University of Medical Sciences 3
The effect of solid lipid nanoparticles containing the parasite Leishmania in vitro Paramomycin 4
An auto machine produces a variety of solutions hematology analyzers 5 Part 5
Effect Of Animal bites that have received post-exposure treatment, vaccination three times 6
The study of the expression of markers of immune response to Mycobacterium tuberculosis-specific antigen using pcr possible to distinguish
between active and latent forms of Mycobacterium tuberculosis 7
Curriculum Vitae Dr. Ali Eslamifar
43
Seroepidemiology of IgG antibodies against diphtheria and tetanus immune level of blood donors living in Arak 8
Quantiferon production of diagnostic kits for detecting active and latent TB infection 9
Production of 4-channel processor machine semi-automatic cytology. 10
Technical knowledge to design and produce the third generation kits based broth 11
Highly sensitive molecular detection kit 11
evaluate the role of PfGCS1 antibody in inhibiting the formation of ovokinet in Anopheles stephensi with the aim of developing a vaccine
against Plasmodium falciparum Transmission Blocking Vaccine 12
DNA evaluation and Live vaccines expressing MHC class I epitopes supply capacities in structure to protect against Lyshnanya major part in a
mouse model Balb / c 13
Curriculum Vitae Dr. Ali Eslamifar
44
Prevalence of hepatitis c virus latent infection in patients undergoing kidney transplant 14
Study of Latent infection and hepatitis B virus vaccine escape mutations in HIV infected patients vaccinated with hepatitis B vaccine 15
Seroepidemiological study of HBV infection and HBV vaccine strains escape mutant vaccine in individuals vaccinated with national
vaccination protocol 22 16
Seroconversion Study in Animal bites that have received post-exposure treatment, vaccination three times 17
Curriculum Vitae Dr. Ali Eslamifar
45
Patents
The names of colleagues Date Title of the invention Cod
Azar Tahghighi, Naser Naghdi, Ali
Eslamifar 1393
The synthesis of the intermediate raw material medicine Cetirizine
hydrochloride hydroxyzine and turn it into crystal form 1
Reza Shirkohi, Monir Salati, Ebrahim
Azizi, Mansour Abachi, Ali Eslamifar 1395
the same molecular personal 9 motation point associated with
thrombophilia with high sensitivity technology based on TaqMan
probe by PCR- Real Time 2
Theses
As the course By Direction Thesis title Cod
M.Sc. Mehdi
Alikhanipor Supervisor
Identify and assess the effects of some herbs on blood coagulation by
comoanformatic 1
M.Sc. Bahareh Soltan
Ahmadi Advisor
Molecular detection of papilloma virus that causes cervical cancer
genotypes in Tehran 2
Curriculum Vitae Dr. Ali Eslamifar
46
PhD Hassan Ebrahimi Advisor Evaluation of brain tumors in vivo in animal models using platinum
Nanvsys 3
M.Sc. Akbar Zahery Supervisor Risk assessment and provide a comprehensive program of HSE
management in the laboratory of Pasteur Institute of Iran, Tehran
specialized services 4
PhD Fardis Tifori Supervisor
Altal in Ltranya and sex-related gene review and evaluate the
allergenic proteins resulting in asthma and allergies in patients with
lower respiratory tract disorders.
5
PhD Elham Mohit Advisor
Construction and evaluation of DNA vaccine defiantly from two
perspectives prevention and treatment of HPV16 E7 gene using with
IP-10, GRP96
6
PhD Negar Seyed Advisor
Design and construction have made what looked like human epitopes
stimulating CD8 cells against Leishmania major, according to In
Silico prediction methods and immunogenicity in HLA transgenic
mice containing human
7
PhD Maryam Barzin Advisor Evaluation of the efficacy and short-term and long-term effects of
bariatric surgery in the treatment of patients with obesity 8
Curriculum Vitae Dr. Ali Eslamifar
47
Teaching Course
Date University As the course Title of course Cod
1384/1 Institute Pasteur of Iran PhD Electron microscopy course 1
1384/1 Institute Pasteur of Iran M.Sc. Electron microscopy course 2
1384/2 Institute Pasteur of Iran M.Sc. Electron microscopy course 3
1384/2 Institute Pasteur of Iran M.Sc. Electron microscopy course 4
1384/2 Institute Pasteur of Iran M.Sc. Electron microscopy course 5
1383/1 Institute Pasteur of Iran M.Sc. Pathology course 6
1383/2 Institute Pasteur of Iran PhD Electron microscopy course 7
1385/1 Institute Pasteur of Iran M.Sc. Electron microscopy course 8
1385/1 Institute Pasteur of Iran PhD Electron microscopy course 9
1385/2 Institute Pasteur of Iran M.Sc. Electron microscopy course 10
1385/2 Institute Pasteur of Iran PhD Electron microscopy course 11
Curriculum Vitae Dr. Ali Eslamifar
48
1386/1 Institute Pasteur of Iran PhD Electron microscopy course 12
1386/2 Institute Pasteur of Iran PhD Electron microscopy course 13
1387/1 Institute Pasteur of Iran PhD Electron microscopy course 14
1387/2 Institute Pasteur of Iran PhD Electron microscopy course 15
1387/2 Institute Pasteur of Iran PhD Electron microscopy course 16
1387/2 Institute Pasteur of Iran M.Sc. Electron microscopy course 17
1388/1 Institute Pasteur of Iran M.Sc. Electron microscopy course 18
1389/1 Institute Pasteur of Iran PhD Electron microscopy course 19
1390/1 Institute Pasteur of Iran PhD Electron microscopy course 20
1391/1 Institute Pasteur of Iran PhD Electron microscopy course 21
1392/1 Institute Pasteur of Iran PhD Electron microscopy course 22
1387/1 Institute Pasteur of Iran M.Sc. Pathology course 23
1388/1 Institute Pasteur of Iran M.Sc. Pathology course 24
Curriculum Vitae Dr. Ali Eslamifar
49
1390/1 Institute Pasteur of Iran M.Sc. Pathology course 25
1391/1 Institute Pasteur of Iran M.Sc. Pathology course 26
1392/1 Institute Pasteur of Iran M.Sc. Pathology course 27
1393/1 Institute Pasteur of Iran M.Sc. Pathology course 28
1394/1 Institute Pasteur of Iran M.Sc. Pathology course 29
Books
Cod Name of Books Publication Date
1 Application of Nanotechnology in Medicine Sharh 1384
2 Guide to antimicrobial therapy Iranian society for infectious diseases and
tropical medicine publicatio
1386, 1387,
1388, 1389
3 Nanotechnology and Medicine Hayyan 1388
4 Guide to antimicrobial therapy and vaccination Poshe 1390
5 Guide to antimicrobial therapy and vaccination Iranian society for infectious diseases and
tropical medicine publicatio 1391
Curriculum Vitae Dr. Ali Eslamifar
50
Membership
Cod Committee
1 Member of Iranian Society of Pathology
2 Member of Iranian Cancer Society
3 Member of Board in Iranian Physician Council
4 Member of Scientific Executive Committee of Iranian Infectious Diseases Conferences
5 Member of Specialized Committee on Research Projects
6 Member of Regional Committee on Ethics
7 Reviewer of Iranian journal of infectious disease and tropical medicin
Curriculum Vitae Dr. Ali Eslamifar
51
Workshops
Cod Name of Cours Date Place
1 Brucellosis Conference 1390 University of Medical Sciences
2 Congress Infectious Diseases and Tropical Medicine 1390 Association of Infectious Diseases and Tropical Medicine
3 Congress Infectious Diseases and Tropical Medicine 1390 Association of Infectious Diseases and Tropical Medicine
4 Third Symposium on Electronic and Telemedicine Hospital 1391 medical University Tehran
5 Congress Infectious Diseases and Tropical Medicine 1390 Association of Infectious Diseases and Tropical Medicine
6 Endocrine pathology program 1392 Association Pathology
7 Blood Bank Program 1392 Association Pathology
8 Microbiology program 1392 Association Pathology
9 Pathology Annual Meeting Iran 1392 Association Pathology
10 Balancing quality control program for clinical laboratories 1392 Medical Council of Islamic Republic of Iran
11 Congress Infectious Diseases and Tropical Medicine 1392 Association of Infectious Diseases and Tropical Medicine
12 Improving quality of services of education Laboratory 1392 Medical Council of Islamic Republic of Iran
13 Conference on biological changes in laboratory 1392 Medical Council of Islamic Republic of Iran
14 Communication between doctor and laboratory conferences 1392 Medical Council of Islamic Republic of Iran
Curriculum Vitae Dr. Ali Eslamifar
52
15 Laboratory status conference on health promotion and patient care 1392 Medical Council of Islamic Republic of Iran
16 Prvssyng workshop, Painting and histopathological examination of
samples sent to pathology labs 1393 Institute Pasteur of Iran
17 Workshop with Electron Microscope SEM 1393 Institute Pasteur of Iran
18 Practical workshops with flow cytometry BD Facscalibur 1393 Institute Pasteur of Iran
19 Seminar with the principles of quality management and internal
audit based on standard requirements 1393 Institute Pasteur of Iran
20 Pathology and Laboratory Medicine Annual Meeting 1393 Association of Infectious Diseases and Tropical Medicine
21 The macroeconomic 1394 Institute Pasteur of Iran
22 Biorisk Management Workshop 1394 Institute Pasteur of Iran
23 Workshop knowledge-based companies 1394 Institute Pasteur of Iran
24 And lead auditor training course documentation and auditing of ISO
/ IEC 1392 ISIRI
25 Future workshops vaccines and drugs industry and economy 1393 Institute Pasteur of Iran
26 Workshop sample management and secure transport
And safety 1392 Reference Laboratory Ministry of Health
27 DNA sequencing 1394 Institute Pasteur of Iran
Curriculum Vitae Dr. Ali Eslamifar
53
28 Confocal microscopy and its applications 1394 Institute Pasteur of Iran
29 Audit Office in collaboration with Middle East TUV.UK & I 1394 Institute Pasteur of Iran
30 Understanding and working with electron microscopy, SEM 1392 Institute Pasteur of Iran
31 Internal audit followed standard requirements ISIRI-ISO 1393 Institute Pasteur of Iran
32 Internal audit followed standard requirements ISIRI-ISO 1393 Institute Pasteur of Iran
33 Design and planning in laboratory quality 1393 Institute Pasteur of Iran
34 Biosafety and Biosecurity Workshop in clinical and research
laboratories 1394 Institute Pasteur of Iran
35 Understanding DNA sequencing and its application 1394 Institute Pasteur of Iran
36 Global Summit for TQM 1393 IRIB International Center of the Islamic Republic of Iran
37 Effective communication organization 1391 Institute Pasteur of Iran
38 operational budgeting 1390 Institute Pasteur of Iran
39 Understanding and working with electron microscopy, SEM 1393 Institute Pasteur of Iran
40 Seminar with the principles of quality management and internal
audit based on standard requirements 1393 Institute Pasteur of Iran